PDE5 inhibitors and satisfaction of patients with erectile dysfunction

被引：1
|
作者：
Cour, F. [1 ]
机构：
[1] Hop La Pitie Salpetriere, Serv Urol, F-75651 Paris 13, France
来源：
PROGRES EN UROLOGIE | 2008年 / 18卷 / 08期
关键词：
D O I：
10.1016/j.purol.2008.04.021
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：542 / 542
页数：1
相关论文
共 50 条
  • [31] Furoyl pyrroloquinolones as selective PDE5 inhibitors for treatment of male erectile dysfunction.
    Jiang, WQ
    Sui, ZH
    Guan, JH
    Macielag, MJ
    Walsh, SP
    Lanter, JC
    Fiordeliso, JJ
    Qiu, YH
    Kraft, P
    Bhattacharjee, S
    Haynes-Johnson, D
    Lombardi, E
    John, TM
    Clancy, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U55 - U56
  • [32] B-carboline as PDE5 inhibitors for treatment of male erectile dysfunction.
    Guan, JH
    Jiang, WQ
    Sui, ZH
    Macielag, MJ
    Walsh, SP
    Lanter, JC
    Fiordeliso, JJ
    Alford, VC
    Qiu, YH
    Patricia, K
    Bhattacharjee, S
    Lombardi, E
    Haynes-Johnson, D
    John, TM
    Clancy, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U55 - U55
  • [33] Effect of Genetic Polymorphism on the Response to PDE5 Inhibitors in Patients With Erectile Dysfunction: A Systematic Review and a Critical Appraisal
    Mostafa, Taymour
    Hassan, Ashraf
    Alghobary, Moheiddin F.
    Abdelrahman, Sherine H.
    SEXUAL MEDICINE REVIEWS, 2020, 8 (04) : 573 - 585
  • [34] Q: What are options for my patients with erectile dysfunction who have an unsatisfactory response to PDE5 inhibitors?
    Hua, Vivian
    Roth, Bradley
    Shumaker, Andrew
    Bole, Raevti
    Bajic, Petar
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2024, 91 (11) : 667 - 670
  • [35] Mirodenafil: a new PDE5 inhibitor for the treatment of erectile dysfunction
    Nature Clinical Practice Urology, 2009, 6 (2): : 60 - 60
  • [36] Physical Activity and PDE5 Inhibitors in the Treatment of Erectile Dysfunction: Results of a Randomized Controlled Study
    Maio, Giuseppe
    Saraeb, Salim
    Marchiori, Antonio
    JOURNAL OF SEXUAL MEDICINE, 2010, 7 (06): : 2201 - 2208
  • [37] Improving Symptoms in Young Men with Erectile Dysfunction: Testosterone Therapy With or Without PDE5 Inhibitors
    Song, J.
    Saffati, G.
    Naeem, T.
    Biles, B.
    Pierce, H.
    Lipshultz, L., I
    Khera, M.
    JOURNAL OF SEXUAL MEDICINE, 2024, 21
  • [38] Quinolines as extremely potent and selective PDE5 inhibitors as potential agents for treatment of erectile dysfunction
    Bi, YZ
    Stoy, P
    Adam, L
    He, B
    Krupinski, J
    Normandin, D
    Pongrac, R
    Seliger, L
    Watson, A
    Macor, JE
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (06) : 1577 - 1580
  • [39] Should physicians prescribe PDE5 inhibitors to sexually healthy males without erectile dysfunction?
    Gruenwald, I
    Appel, B.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E702 - U496
  • [40] Substituted pyrazolopyridines as potent and selective PDE5 inhibitors: Potential agents for treatment of erectile dysfunction
    Yu, GX
    Mason, HJ
    Wu, XM
    Wang, J
    Chong, SH
    Dorough, G
    Henwood, A
    Pongrac, R
    Seliger, L
    He, B
    Normandin, D
    Adam, L
    Krupinski, J
    Macor, JE
    JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (07) : 1025 - 1027
12345